Western Digital Corp. (WDC - Free Report) is dealing with soft market conditions. This Zacks #5 (Strong Sell) as sales are expected to be down 19.4% year-over-year.
Western Digital provides storage solutions for data, including data centers and mobile sensors to personal devices. It's brands included Western Digital, G-Technology, SanDisk and WD.
A Miss in the Fiscal Third Quarter
On Apr 29, Western Digital reported its fiscal third quarter earnings report and missed on the Zacks Consensus Estimate by 32 cents. Earnings were $0.17 versus the consensus of $0.49.
“Market conditions have generally been consistent with our expectations, and while the business environment remains soft, there are initial indications of improving trends,” said Steve Milligan, chief executive officer, Western Digital.
“Our expectation for the demand environment to further improve for both flash and hard drive products for the balance of calendar 2019 is largely unchanged. We are executing well on enhancing our product portfolio, driving technology advancements, rightsizing our factory production levels and lowering our cost and expense structure, all of which position us to emerge stronger as market conditions improve.”
Analysts Cut Estimates
The analysts cut estimates after this miss.
9 estimates were cut in the last month, which has pushed the Zacks Consensus down to $4.88 from $5.55.
That's a decline of 67% from the $14.73 it made last year.
8 estimates were also slashed in the prior 30 days on fiscal 2020. The consensus has sunk to $3.72 from $5.18, that's another 23% decline.
Shares Rebound Off Lows
Shares have been under pressure over the last year. They've fallen 40%.
But they've rebounded in 2019 and are now up 26%.
Western Digital is still cheap, with a forward P/E of 9.7. But it's unclear if the earnings slide is over.
For those interested in this space, you may want to look at Seagate Technology (STX - Free Report) which is a Zacks Rank #3 (Hold). It's also cheap with a forward P/E of 10.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>